Clinical trial
Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
NCT04135287 is registered in ClinicalTrials.gov with Dasman Diabetes Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Lead sponsor
- Dasman Diabetes Institute
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 1, 2020
- Completion date
- July 15, 2023
- Enrollment
- 315 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.